NEVVI Medicare utilization intelligence

← back

TORRES GONZALEZ, ALFREDOM.D NPI 1285977546 Clinician

Hematology-Oncology · PORT JEFFERSON STATION, NY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 18 years since medical school (class of 2008, self-reported to CMS)
Location PORT JEFFERSON STATION, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 125 codes billed · 211,485 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20202026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2020–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-04

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J0897 Injection, denosumab, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
83735 Magnesium level
84550 Uric acid level, blood
83615 Lactate dehydrogenase (enzyme) level
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
84100 Phosphate level
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
82784 Gammaglobulin (immune system protein) measurement
82607 Cyanocobalamin (vitamin b-12) level
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
82746 Folic acid level, serum
82378 Carcinoembryonic antigen (cea) protein level
82306 Vitamin d-3 level
96372 Injection of drug or substance under skin or into muscle
83521 Measurement of immunoglobulin light chains
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
84153 Psa (prostate specific antigen) measurement, total
84443 Blood test, thyroid stimulating hormone (tsh)
85044 Red blood count, manual test
J3475 Injection, magnesium sulfate, per 500 mg
84165 Protein measurement, serum
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96375 Injection of additional new drug or substance into vein
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
86334 Immunologic analysis technique on serum (immunofixation)
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
J2405 Injection, ondansetron hydrochloride, per 1 mg
84403 Testosterone (hormone) level, total
82232 Beta-2 microglobulin (protein) level
96374 Injection of drug or substance into vein
85610 Blood test, clotting time
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96361 Infusion into a vein for hydration, each additional hour
J9045 Injection, carboplatin, 50 mg
88184 Flow cytometry technique for dna or cell analysis, first marker
80047 Blood test, basic group of blood chemicals (calcium, ionized)
85014 Red blood cell concentration measurement
83036 Hemoglobin a1c level
84436 Thyroxine (thyroid chemical), total
96360 Infusion into a vein for hydration, 31-60 minutes
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
84439 Thyroxine (thyroid chemical), free
80307 Testing for presence of drug, by chemistry analyzers
81002 Urinalysis, manual test
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
82533 Cortisol (hormone) measurement, total
87529 Detection test by nucleic acid for herpes simplex virus, amplified probe technique
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
83010 Haptoglobin (serum protein) level
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
80076 Liver function blood test panel
82565 Blood creatinine level
84520 Urea nitrogen level to assess kidney function, quantitative
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
J7030 Infusion, normal saline solution , 1000 cc
83970 Parathormone (parathyroid hormone) level
J7050 Infusion, normal saline solution, 250 cc
99195 Drawing of blood for a medical problem
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
82310 Calcium level, total
96415 Administration of chemotherapy into vein, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
G0008 Administration of influenza virus vaccine
82668 Erythropoietin (protein) level
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
82670 Measurement of total estradiol (hormone)
96417 Administration of additional new drug or substance into vein, 1 hour or less
80074 Acute hepatitis panel
87511 Detection test for gardnerella vaginalis (bacteria), amplified probe technique
87661 Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique
80061 Blood test, lipids (cholesterol and triglycerides)
82248 Bilirubin level, direct
82785 Ige (immune system protein) level
86141 Measurement c-reactive protein for detection of infection or inflammation, high sensitivity
90662 Influenza vaccine split virus, preservative free
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96411 Administration of additional new drug or substance into vein using push technique
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
86038 Screening test for autoimmune disorder
88377 Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure
J2060 Injection, lorazepam, 2 mg
82105 Alpha-fetoprotein (afp) level, serum
82947 Blood glucose (sugar) level
96523 Irrigation of implanted venous access drug delivery device
90653 Influenza vaccine, inactivated
99495 Transitional care management services for problem of at least moderate complexity
83001 Gonadotropin, follicle stimulating (reproductive hormone) level
77080 Dxa bone density measurement of hip, pelvis, spine
80048 Blood test, basic group of blood chemicals (calcium, total)
82550 Creatine kinase (cardiac enzyme) level, total
83002 Gonadotropin, luteinizing (reproductive hormone) level
86431 Rheumatoid factor level
84479 Thyroid hormone evaluation
85536 Blood smear for iron
86618 Analysis for antibody borrelia burgdorferi (lyme disease bacteria)
87491 Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique
87591 Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique
84146 Prolactin (milk producing hormone) level
99496 Transitional care management services for problem of high complexity
87389 Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies
G0452 Molecular pathology procedure; physician interpretation and report
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
85730 Coagulation assessment blood test, plasma or whole blood
83090 Homocysteine (amino acid) level
82270 Stool analysis for blood to screen for colon tumors

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.